<DOC>
	<DOCNO>NCT01887847</DOCNO>
	<brief_summary>The objective study compare pharmacokinetics investigational 2 mg sublingual nicotine tablet ( Pharmaceutical Productions Inc. ) 2 mg CommitÂ® nicotine lozenge ( GlaxoSmith Kline ) randomize crossover design 6 male female otherwise healthy smoker .</brief_summary>
	<brief_title>Pilot Pharmacokinetic Study Investigational Sublingual Nicotine Tablet Versus COMMIT Nicotine Lozenge</brief_title>
	<detailed_description>A single oral dose medication administer participant 48 hour washout period administration . Serial blood sample obtain follow time administration nicotine dosage form : 0 , 4 , 8 , 10 , 12 , 16 , 30 , 45 , 60 , 90 , 120 , 180 minute . Vital sign obtain prior dose 30 , 60 , 180 , 240 minute dosage administration . A craving questionnaire administer prior dose 5 , 11 , 17 , 25 , 35 , 50 , 65 minute . Craving questionnaire administer 30 minute interval thereafter 180 minute medication administration . A Product Preference Questionnaire complete end second study period . A 30 day follow-up visit schedule participant conclusion study</detailed_description>
	<mesh_term>Nicotine</mesh_term>
	<criteria>Subjects 1845 year old Subjects must provide write informed consent prior study related procedure perform . Subjects must willingness ability comply protocol requirement . Subjects must good health free clinically significant pathology ( gastrointestinal tract , hepatic , renal , cardiovascular , central nervous system disease ) Subjects must body mass index exceed 35 Female subject childbearing potential , addition negative urine pregnancy test , must willing use form birth control study . The hormonal contraceptive avoid within 2 month prior study entry . Subjects must consume 15 cigarette daily smoke first cigarette within 30 minute awake sleeping . A Fagerstrom Smoking index great 4 Subjects use nicotine delivery system nicotine lozenge , nicotine patch , nicotine inhaler , nicotine nasal spray etc . within 30 day study entry . Subjects smoke substance tobacco within 30 day study entry . Subjects use smoke cessation aid ( include bupropion , herbal , counseling , etc . ) within 30 day study entry . Subjects currently involve another clinical trial use investigational drug within 3 month study entry . Subject pregnant lactating , plan become pregnant within 6 month . Subjects diagnose heart disease treat medication irregular heartbeat heart attack . Subject diagnose stomach ulcer . Subjects take insulin diabetes . Subjects high blood pressure control medication blood pressure great 150 mmHg systolic 90 mmHg diastolic Subjects unable fulfill study requirement relation conform visit schedule . Subjects severe allergic history Subjects know intolerance medication Subjects diagnose chronic disease cardiovascular , pulmonary , neuroendocrine system , gastrointestinal , hepatic , renal , blood disease Subjects surgical operation gastrointestinal tract exception appendectomy Subjects acute infectious disease within last 4 week prior study entry ; Subjects donate 450 mL his/her blood blood plasma within last 2 month prior study entry Subjects take 10 unit alcohol per week history alcohol drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>nicotine</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>